A950140 Stock Overview
Engages in the research and development, manufacture, sale, and distribution of cosmetic products in the United States, Canada, China, Korea, Europe, Southeast Asia, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Englewood Lab, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩12,200.00 |
| 52 Week High | ₩28,300.00 |
| 52 Week Low | ₩10,570.00 |
| Beta | 0.72 |
| 11 Month Change | -44.16% |
| 3 Month Change | -44.80% |
| 1 Year Change | 11.11% |
| 33 Year Change | 20.79% |
| 5 Year Change | 133.72% |
| Change since IPO | 67.12% |
Recent News & Updates
Englewood Lab, Inc. (KOSDAQ:950140) Stocks Pounded By 28% But Not Lagging Market On Growth Or Pricing
Aug 07
We Think Englewood Lab (KOSDAQ:950140) Can Manage Its Debt With Ease
Jun 20Recent updates
Englewood Lab, Inc. (KOSDAQ:950140) Stocks Pounded By 28% But Not Lagging Market On Growth Or Pricing
Aug 07We Think Englewood Lab (KOSDAQ:950140) Can Manage Its Debt With Ease
Jun 20Is Now The Time To Put Englewood Lab (KOSDAQ:950140) On Your Watchlist?
May 24A Piece Of The Puzzle Missing From Englewood Lab, Inc.'s (KOSDAQ:950140) 25% Share Price Climb
May 09Investors Shouldn't Overlook Englewood Lab's (KOSDAQ:950140) Impressive Returns On Capital
May 08When Should You Buy Englewood Lab, Inc. (KOSDAQ:950140)?
Apr 16There Are Reasons To Feel Uneasy About Englewood Lab's (KOSDAQ:950140) Returns On Capital
Mar 31If You Had Bought Englewood Lab (KOSDAQ:950140) Shares A Year Ago You'd Have Earned 106% Returns
Mar 17What Kind Of Shareholders Hold The Majority In Englewood Lab, Inc.'s (KOSDAQ:950140) Shares?
Feb 23These 4 Measures Indicate That Englewood Lab (KOSDAQ:950140) Is Using Debt Reasonably Well
Feb 05
Englewood Lab, Inc. (KOSDAQ:950140) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?
Jan 20Is Englewood Lab, Inc. (KOSDAQ:950140) Potentially Undervalued?
Jan 02Returns On Capital At Englewood Lab (KOSDAQ:950140) Paint An Interesting Picture
Dec 15Are Englewood Lab's (KOSDAQ:950140) Statutory Earnings A Good Reflection Of Its Earnings Potential?
Nov 26Shareholder Returns
| A950140 | KR Professional Services | KR Market | |
|---|---|---|---|
| 7D | -11.2% | 0.1% | 0.4% |
| 1Y | 11.1% | -13.9% | 2.8% |
Return vs Industry: A950140 exceeded the KR Professional Services industry which returned -13.9% over the past year.
Return vs Market: A950140 exceeded the KR Market which returned 2.8% over the past year.
Price Volatility
| A950140 volatility | |
|---|---|
| A950140 Average Weekly Movement | 11.9% |
| Professional Services Industry Average Movement | 6.7% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in KR Market | 12.1% |
| 10% least volatile stocks in KR Market | 3.4% |
Stable Share Price: A950140's share price has been volatile over the past 3 months.
Volatility Over Time: A950140's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of KR stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | 178 | Henry Cho | www.englewoodlab.com |
Englewood Lab, Inc. engages in the research and development, manufacture, sale, and distribution of cosmetic products in the United States, Canada, China, Korea, Europe, Southeast Asia, and internationally. The company offers skincare products, such as oils, creams, serums, cleansers, and masks; hybrid beauty products, including primers and foundations, BB and CC creams, concealers, blushes and illuminizers, bronzer highlighters, and lip care products; and SPF/ACNE, personal hygiene, and skin protectant over the counter products. The company was founded in 2004 and is headquartered in Totowa, New Jersey.
Englewood Lab, Inc. Fundamentals Summary
| A950140 fundamental statistics | |
|---|---|
| Market cap | ₩242.39b |
| Earnings (TTM) | ₩22.33b |
| Revenue (TTM) | ₩210.19b |
10.9x
P/E Ratio1.2x
P/S RatioIs A950140 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A950140 income statement (TTM) | |
|---|---|
| Revenue | ₩210.19b |
| Cost of Revenue | ₩161.90b |
| Gross Profit | ₩48.30b |
| Other Expenses | ₩25.97b |
| Earnings | ₩22.33b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.12k |
| Gross Margin | 22.98% |
| Net Profit Margin | 10.62% |
| Debt/Equity Ratio | 9.7% |
How did A950140 perform over the long term?
See historical performance and comparison